RE: Connecting the dots4 Jun 2022 13:46
good thought on, Professor UdaiProfessor Udai Banerji.. GF'' as he was involve with
SRA737 at one point, and would know how good it is, in solid tumor, and perhaps a lot more
and although that article might not be related to us, as some has said, its a good find
where connecting the dot with DR Udai Banerji. and Royal Marsden 2018
is concerned, as Sierra did say around that time and was very excited
about FDA regulatory submit for SRA737 Q3 2018?? and the rest is history..
let's see what happen in Q3 SEPT, when GSK expect the deal with Sierra to be all tied up
and signed off hopefully we will here more about what they intend to do with Sierra
other 2 asset SRA737 P2?? / SRA515 P1, will it finally after 4 years waiting git to see the regulators
with GSK at the helm??
BTW although we had a disruptive BB attack yesterday we certainly got noticed
in the most talk about stock forum with 65 post of dribble LOL!!
for every negative there is a positive for someone, the same as WAR and oil price
food and everything else, our turn is coming